Back
Blueprint Medicines Vs. Alnylam Pharmaceuticals Industry Stock Comparison
Buy
58
BPMC
Blueprint Medicines
Last Price:
103.68
Seasonality Move:
6.04%
Sell
32
ALNY
Alnylam Pharmaceuticals
Last Price:
150.77
Seasonality Move:
17.83%
Buy
58
Blueprint Medicines (BPMC)
is a Buy
Is Blueprint Medicines a Buy, Sell or Hold?
- The current Blueprint Medicines [BPMC] share price is $104.26. The Score for BPMC is 58, which is 16% above its historic median score of 50, and infers lower risk than normal.
- BPMC is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
32
Alnylam Pharmaceuticals (ALNY)
is a Sell
Is Alnylam Pharmaceuticals a Buy, Sell or Hold?
- The current Alnylam Pharmaceuticals [ALNY] share price is $150.24. The Score for ALNY is 32, which is 36% below its historic median score of 50, and infers higher risk than normal.
- ALNY is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
BPMC Stock Price Chart
What is Blueprint Medicines's stock price today?
-
The Blueprint Medicines share price today is $104.26
The current trend is moderately bullish and BPMC is experiencing slight selling pressure.
ALNY Stock Price Chart
What is Alnylam Pharmaceuticals's stock price today?
-
The Alnylam Pharmaceuticals share price today is $150.24
The current trend is relatively stagnant and ALNY is experiencing buying pressure, which is a positive indicator for future bullish movement.
BPMC Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 3.82 | Buy |
| Relative Strength Index (14 RSI): | 58.18 | Buy |
| Chaikin Money Flow: | -192013 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (90.81 - 107.43) | Buy |
| Bollinger Bands (100): | (81.36 - 98.4) | Buy |
ALNY Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.13 | Buy |
| Relative Strength Index (14 RSI): | 51.38 | Buy |
| Chaikin Money Flow: | 234808 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (145 - 151.3) | Buy |
| Bollinger Bands (100): | (144.24 - 178.48) | Sell |
BPMC Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 106.42 | Sell |
| 20-day SMA: | 101.85 | Buy |
| 50-day SMA: | 94.71 | Buy |
| 200-day SMA: | 73.99 | Buy |
| 8-day EMA: | 105.47 | Sell |
| 20-day EMA: | 102.33 | Buy |
| 50-day EMA: | 96.35 | Buy |
| 200-day EMA: | 79.65 | Buy |
ALNY Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 149.74 | Buy |
| 20-day SMA: | 148.82 | Buy |
| 50-day SMA: | 149.26 | Buy |
| 200-day SMA: | 168.98 | Sell |
| 8-day EMA: | 149.82 | Buy |
| 20-day EMA: | 149.52 | Buy |
| 50-day EMA: | 151.53 | Sell |
| 200-day EMA: | 167.11 | Sell |
Blueprint Medicines Earnings Growth & BPMC Earnings Dates
- Analysts estimate an earnings increase this quarter of $1.17 per share, an increase next quarter of $0.33 per share, an increase this year of $5.90 per share, and an increase next year of $0.62 per share.
Alnylam Pharmaceuticals Earnings Growth & ALNY Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.34 per share, a decrease next quarter of $0.14 per share, a decrease this year of $0.52 per share, and an increase next year of $1.84 per share.
Blueprint Medicines Technical Analysis
| May 7 | May 8 | May 9 | May 10 | May 13 | May 14 | May 15 | May 16 | May 17 | May 20 | |
|---|---|---|---|---|---|---|---|---|---|---|
| May | ||||||||||
| 07 | 08 | 09 | 10 | 13 | 14 | 15 | 16 | 17 | 20 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Alnylam Pharmaceuticals Technical Analysis
| May 7 | May 8 | May 9 | May 10 | May 13 | May 14 | May 15 | May 16 | May 17 | May 20 | |
|---|---|---|---|---|---|---|---|---|---|---|
| May | ||||||||||
| 07 | 08 | 09 | 10 | 13 | 14 | 15 | 16 | 17 | 20 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||